Bacterial lysates improve the protective antibody response against respiratory viruses through Toll-like receptor 4

Understanding Respiratory Syncytial Virus Infection to Improve Treatment and Immunity

(2013) P. Gonzalez et al.   CURRENT MOLECULAR MEDICINE

Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial

(2012) Susanne Lau et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells

(2010) YanMei Liang et al.   CLINICAL IMMUNOLOGY

The bacterial extract OM-85 BV protects mice against Influenza and Salmonella infection

(2010) Wolfgang G. Bessler et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

(2010) Taro Kawai et al.   NATURE IMMUNOLOGY

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

(2010) Ana Clara Monsalvo et al.   NATURE MEDICINE

A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines

(2010) Rhea N. Coler et al.   PLoS One

Pandemic H1N1 2009 Influenza A Virus Induces Weak Cytokine Responses in Human Macrophages and Dendritic Cells and Is Highly Sensitive to the Antiviral Actions of Interferons

(2009) P. Osterlund et al.   JOURNAL OF VIROLOGY

Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1) in Argentina

(2009) Romina Libster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

(2008) Maria Florencia Delgado et al.   NATURE MEDICINE